Home›Companies›Healthcare›RegenMed

RegenMed, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 18, 2025·Suggest an edit

About RegenMed

RegenMed is a private company based in Greenwich, Connecticut, incorporated in 2024 in Delaware. It has reported $290,000 raised in one offering on Form D since February 2025. Its chief executive is Michael Tierney.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 5, 2025Feb 18, 2025$290,000target not set2$145KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on RegenMed's Form D filed Feb 18, 2025.

MT
Michael Tierney
Chief Executive Officer and director
SR
Susan Ryder
Executive officer and director
JF

Sources

  1. SECRegenMed, Inc. filing history